Endocyte: Vitamins as transporters

By Steve Edelson

Staff Writer A primary problem for companies developing cancer therapeutics is the systemic side effects that arise from compounds lacking specificity for tumor cells. Endocyte Inc. hopes to solve this problem with technology that links cancer compounds to folate, a vitamin whose receptor is overexpressed on tumor cells. ...